Cetera Advisor Networks’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.73M Buy
8,009
+1,689
+27% +$396K 0.01% 1108
2023
Q4
$1.64M Buy
6,320
+230
+4% +$56.5K 0.01% 1071
2023
Q3
$1.57M Buy
6,090
+374
+7% +$100K 0.01% 1020
2023
Q2
$1.63M Buy
5,716
+438
+8% +$130K 0.01% 959
2023
Q1
$1.47M Buy
5,278
+1,030
+24% +$285K 0.01% 1002
2022
Q4
$1.18M Buy
4,248
+2,063
+94% +$583K 0.01% 1096
2022
Q3
$583K Buy
2,185
+146
+7% +$31K 0.01% 1183
2022
Q2
$415K Buy
2,039
+225
+12% +$46K 0.01% 1397
2022
Q1
$382K Sell
1,814
-8
-0.4% -$1.74K ﹤0.01% 1480
2021
Q4
$437K Sell
1,822
-1,413
-44% -$363K 0.01% 1354
2021
Q3
$915K Buy
3,235
+126
+4% +$41.3K 0.01% 887
2021
Q2
$1.08M Buy
3,109
+1,323
+74% +$401K 0.02% 800
2021
Q1
$500K Buy
1,786
+68
+4% +$18.3K 0.01% 874
2020
Q4
$421K Buy
1,718
+42
+3% +$10.8K 0.01% 864
2020
Q3
$475K Sell
1,676
-148
-8% -$41.3K 0.01% 727
2020
Q2
$488K Sell
1,824
-155
-8% -$46.6K 0.01% 703
2020
Q1
$626K Sell
1,979
-140
-7% -$42.5K 0.02% 544
2019
Q4
$629K Buy
2,119
+266
+14% +$73.8K 0.02% 651
2019
Q3
$430K Sell
1,853
-509
-22% -$119K 0.01% 756
2019
Q2
$551K Sell
2,362
-714
-23% -$165K 0.02% 644
2019
Q1
$727K Buy
3,076
+182
+6% +$57.3K 0.02% 541
2018
Q4
$873K Buy
2,894
+701
+32% +$224K 0.03% 406
2018
Q3
$775K Buy
2,193
+113
+5% +$38.9K 0.03% 494
2018
Q2
$605K Sell
2,080
-1,179
-36% -$331K 0.03% 423
2018
Q1
$895K Sell
3,259
-228
-7% -$70.8K 0.04% 350
2017
Q4
$1.11M Buy
3,487
+852
+32% +$273K 0.05% 333
2017
Q3
$826K Buy
2,635
+237
+10% +$70.2K 0.04% 385
2017
Q2
$651K Sell
2,398
-160
-6% -$42.3K 0.03% 442
2017
Q1
$703K Buy
2,558
+144
+6% +$40.7K 0.03% 404
2016
Q4
$686K Sell
2,414
-659
-21% -$195K 0.04% 387
2016
Q3
$962K Buy
3,073
+220
+8% +$65.2K 0.04% 387
2016
Q2
$689K Sell
2,853
-247
-8% -$65.1K 0.04% 361
2016
Q1
$810K Buy
3,100
+172
+6% +$45.4K 0.05% 328
2015
Q4
$897K Buy
2,928
+669
+30% +$192K 0.06% 296
2015
Q3
$659K Sell
2,259
-467
-17% -$154K 0.05% 353
2015
Q2
$1.15M Hold
2,726
0.07% 260
2015
Q1
$1.15M Sell
2,726
-1,212
-31% -$478K 0.07% 261
2014
Q4
$1.33M Buy
3,938
+541
+16% +$175K 0.09% 218
2014
Q3
$1.12M Buy
3,397
+811
+31% +$267K 0.08% 253
2014
Q2
$820K Buy
2,586
+26
+1% +$7.83K 0.05% 342
2014
Q1
$785K Buy
2,560
+146
+6% +$46.3K 0.06% 329
2013
Q4
$674K Sell
2,414
-100
-4% -$25.9K 0.05% 346
2013
Q3
$604K Buy
2,514
+325
+15% +$72.7K 0.05% 322
2013
Q2
$472K Buy
+2,189
New +$468K 0.05% 326

Other funds holding BIIB

Cetera Advisor Networks's BIIB Position: Q1 2024 in Review

Cetera Advisor Networks increased its Biogen (BIIB) stake by 27% in Q1 2024, buying an estimated $396K and bringing the position to 8,009 shares worth $1.73M. The position accounts for 0.01% of the portfolio, ranked #1108.

Cetera Advisor Networks first reported a position in BIIB in Q2 2013 and has held it in 44 quarters since. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Cetera Advisor Networks held 8,009 shares of Biogen worth $1.73M as of Q1 2024.
  • Cetera Advisor Networks bought 1,689 Biogen shares in Q1 2024, an estimated $396K.
  • Biogen made up 0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1108 holding.
  • Cetera Advisor Networks first reported a position in Biogen in Q2 2013 and has held it in 44 quarters since.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.